Linden Capital Partners Received Investment By Lunate Capital and Blue Owl’s GP Strategic Capital Platform

Illinois-based, Linden Capital Partners a life science and healthcare private equity company recently announced its minority investment from Lunate Capital and GP Strategic Capital Platform (Blue Owl-owned company).

The investment amount is not disclosed by any of the group but the investment is done via joint venture.

Linden Capital Partners Received Investment

CEO of Linden Capital Partners, Tony Davis said that the received funds will enable Linden Capital Partners to focus on three key principles.

Linden mainly invests in pharmaceuticals, medical products, and services. Tony further said that Linden is invested in more than 45 healthcare companies with over $8.0 Billion AUM.

Also Read: Bluewhite Raised $39M Series C

By Admin

Leave a Reply

Your email address will not be published. Required fields are marked *